|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.98 USD | -1.12% |
|
+3.57% | +9.07% |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 12.13 | 7.26 | 8.39 | 9.84 | 13.09 | |||||
Return on Total Capital | 19.46 | 11.9 | 14.11 | 17 | 21.7 | |||||
Return On Equity % | 95.87 | 71.31 | 28.83 | 66.36 | 169.2 | |||||
Return on Common Equity | 107.66 | 95.55 | 38.4 | 102.19 | 249.61 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 43.58 | 35.81 | 39.32 | 43.21 | 45.16 | |||||
SG&A Margin | 24.64 | 23.62 | 26 | 27.99 | 26.69 | |||||
EBITDA Margin % | 19.38 | 13.25 | 14.05 | 16.16 | 19.66 | |||||
EBITA Margin % | 17.03 | 10.65 | 11.4 | 13.39 | 16.98 | |||||
EBIT Margin % | 16.59 | 10.22 | 10.99 | 12.98 | 16.68 | |||||
Income From Continuing Operations Margin % | 9.79 | 6.63 | 2.18 | 4.12 | 11.6 | |||||
Net Income Margin % | 9.67 | 6.5 | 2.02 | 3.95 | 11.4 | |||||
Net Avail. For Common Margin % | 9.67 | 6.5 | 2.02 | 3.95 | 11.4 | |||||
Normalized Net Income Margin | 9.4 | 5.4 | 6 | 7.18 | 9.55 | |||||
Levered Free Cash Flow Margin | 7.99 | 2.44 | 12.47 | 5.07 | 15.27 | |||||
Unlevered Free Cash Flow Margin | 8.83 | 3.37 | 13.23 | 5.86 | 16.04 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.17 | 1.14 | 1.22 | 1.21 | 1.26 | |||||
Fixed Assets Turnover | 4.8 | 4.25 | 4.33 | 4.14 | 4.25 | |||||
Receivables Turnover (Average Receivables) | 12.13 | 11.45 | 11.09 | 10.67 | 9.72 | |||||
Inventory Turnover (Average Inventory) | 6.87 | 6.05 | 6.18 | 6.04 | 6.72 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.89 | 0.97 | 0.95 | 1.03 | 0.84 | |||||
Quick Ratio | 0.45 | 0.48 | 0.55 | 0.57 | 0.51 | |||||
Operating Cash Flow to Current Liabilities | 0.62 | 0.44 | 0.6 | 0.44 | 0.51 | |||||
Days Sales Outstanding (Average Receivables) | 30.08 | 31.87 | 32.92 | 34.31 | 37.53 | |||||
Days Outstanding Inventory (Average Inventory) | 53.14 | 60.29 | 59.06 | 60.56 | 54.34 | |||||
Average Days Payable Outstanding | 61.86 | 75.56 | 93.91 | 90.88 | 99.74 | |||||
Cash Conversion Cycle (Average Days) | 21.36 | 16.6 | -1.93 | 4 | -7.87 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 538.18 | 428.26 | 761.34 | 596.95 | 604.98 | |||||
Total Debt / Total Capital | 84.33 | 81.07 | 88.39 | 85.65 | 85.82 | |||||
LT Debt/Equity | 472.97 | 384.22 | 723.71 | 576.42 | 582.99 | |||||
Long-Term Debt / Total Capital | 74.11 | 72.73 | 84.02 | 82.71 | 82.7 | |||||
Total Liabilities / Total Assets | 90.65 | 88.16 | 93.47 | 91.44 | 91.33 | |||||
EBIT / Interest Expense | 12.3 | 6.85 | 9.02 | 10.23 | 13.47 | |||||
EBITDA / Interest Expense | 15.53 | 10.48 | 13.53 | 14.89 | 17.69 | |||||
(EBITDA - Capex) / Interest Expense | 12.18 | 8.11 | 11 | 12.53 | 15.19 | |||||
Total Debt / EBITDA | 2.07 | 2.81 | 2.43 | 2.19 | 1.87 | |||||
Net Debt / EBITDA | 1.87 | 2.65 | 2.12 | 2.04 | 1.77 | |||||
Total Debt / (EBITDA - Capex) | 2.64 | 3.63 | 2.98 | 2.6 | 2.18 | |||||
Net Debt / (EBITDA - Capex) | 2.38 | 3.42 | 2.61 | 2.42 | 2.06 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 9.22 | -3.19 | 3.97 | -4.01 | 0.16 | |||||
Gross Profit, 1 Yr. Growth % | 4.44 | -20.44 | 14.15 | 5.51 | 4.67 | |||||
EBITDA, 1 Yr. Growth % | -0.21 | -33.8 | 11.85 | 10.4 | 21.9 | |||||
EBITA, 1 Yr. Growth % | -1.19 | -39.44 | 13.32 | 12.83 | 26.95 | |||||
EBIT, 1 Yr. Growth % | -2.64 | -40.39 | 14.04 | 13.42 | 28.66 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -23.43 | -34.49 | -65.82 | 81.37 | 182.19 | |||||
Net Income, 1 Yr. Growth % | -24.39 | -34.93 | -67.75 | 87.92 | 189.29 | |||||
Normalized Net Income, 1 Yr. Growth % | -5.35 | -44.45 | 18.38 | 14.79 | 33.24 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -24.18 | -33.15 | -67.83 | 87.5 | 189.78 | |||||
Accounts Receivable, 1 Yr. Growth % | -7.32 | 13.23 | 2.28 | -2.67 | 22.71 | |||||
Inventory, 1 Yr. Growth % | 65.64 | 0.4 | -7.81 | -8.48 | -17.9 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 17.4 | 2.48 | 1.53 | -0.7 | -4.27 | |||||
Total Assets, 1 Yr. Growth % | 1.95 | -2.78 | -3.46 | -3.26 | -3.3 | |||||
Tangible Book Value, 1 Yr. Growth % | 33.21 | -9.41 | -7.53 | -9.35 | -6.77 | |||||
Common Equity, 1 Yr. Growth % | -54.74 | 35.28 | -60.43 | 49.09 | -2.13 | |||||
Cash From Operations, 1 Yr. Growth % | -17.46 | -38.4 | 47.33 | -39.98 | 41.15 | |||||
Capital Expenditures, 1 Yr. Growth % | 30.31 | -24.17 | -9.16 | -7.02 | 3.77 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -44.1 | -70.41 | 459.18 | -60.99 | 201.81 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -41.65 | -63.02 | 323.16 | -57.48 | 174.2 | |||||
Dividend Per Share, 1 Yr. Growth % | 4.66 | 3.79 | 1.72 | 1.69 | 1.66 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.69 | 2.83 | 0.33 | -0.1 | -1.95 | |||||
Gross Profit, 2 Yr. CAGR % | 8.29 | -8.85 | -4.91 | 9.74 | 5.09 | |||||
EBITDA, 2 Yr. CAGR % | 5.6 | -18.72 | -15.01 | 11.13 | 16.01 | |||||
EBITA, 2 Yr. CAGR % | 5.69 | -22.64 | -18.38 | 13.08 | 19.68 | |||||
EBIT, 2 Yr. CAGR % | 5.04 | -23.82 | -18.82 | 13.73 | 20.8 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -6.36 | -29.18 | -52.68 | -21.26 | 126.23 | |||||
Net Income, 2 Yr. CAGR % | -6.95 | -29.86 | -54.19 | -22.15 | 133.16 | |||||
Normalized Net Income, 2 Yr. CAGR % | 4.17 | -27.49 | -20.34 | 16.57 | 23.67 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -6.04 | -28.81 | -53.63 | -22.33 | 133.1 | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.64 | 2.44 | 7.61 | -0.23 | 9.29 | |||||
Inventory, 2 Yr. CAGR % | 21.19 | 28.96 | -3.8 | -8.15 | -13.31 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 26.44 | 9.69 | 2.01 | 0.41 | -2.5 | |||||
Total Assets, 2 Yr. CAGR % | 11.27 | -0.44 | -3.12 | -3.36 | -3.28 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.49 | 9.85 | -8.48 | -8.44 | -8.07 | |||||
Common Equity, 2 Yr. CAGR % | -14.25 | -21.75 | -26.84 | -23.19 | 20.79 | |||||
Cash From Operations, 2 Yr. CAGR % | 13.41 | -28.7 | -4.74 | -5.97 | -7.96 | |||||
Capital Expenditures, 2 Yr. CAGR % | 26.76 | -0.59 | -17 | -8.1 | -1.77 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -6.82 | -59.33 | 24.42 | 47.69 | 8.51 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -6.15 | -53.54 | 21.98 | 34.14 | 7.97 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.75 | 4.22 | 2.75 | 1.7 | 1.67 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.23 | 4.58 | 3.21 | -1.14 | -0.01 | |||||
Gross Profit, 3 Yr. CAGR % | 6.14 | -2.29 | -1.75 | -1.56 | 8.02 | |||||
EBITDA, 3 Yr. CAGR % | 3.59 | -9.62 | -10.04 | -7.27 | 14.61 | |||||
EBITA, 3 Yr. CAGR % | 3.27 | -12.21 | -12.69 | -9.08 | 17.52 | |||||
EBIT, 3 Yr. CAGR % | 2.68 | -13.04 | -13.42 | -9.24 | 18.51 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -4.4 | -16.87 | -44.45 | -25.95 | 20.49 | |||||
Net Income, 3 Yr. CAGR % | -4.8 | -17.41 | -45.86 | -26.67 | 20.58 | |||||
Normalized Net Income, 3 Yr. CAGR % | 1.54 | -15.53 | -15.27 | -10.02 | 21.88 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -3.76 | -16.12 | -45.37 | -26.12 | 20.46 | |||||
Accounts Receivable, 3 Yr. CAGR % | -0.45 | 2.39 | 2.38 | 4.07 | 6.9 | |||||
Inventory, 3 Yr. CAGR % | 14.12 | 13.82 | 15.31 | -5.38 | -11.52 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 18.4 | 17.89 | 6.9 | 1.1 | -1.17 | |||||
Total Assets, 3 Yr. CAGR % | 7.77 | 6.37 | -1.46 | -3.17 | -3.34 | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.87 | -1 | 3.72 | -8.77 | -7.89 | |||||
Common Equity, 3 Yr. CAGR % | -17.28 | -0.18 | -37.66 | -7.24 | -16.73 | |||||
Cash From Operations, 3 Yr. CAGR % | 9.35 | -7.47 | -9.18 | -18.33 | 7.67 | |||||
Capital Expenditures, 3 Yr. CAGR % | 19.49 | 6.81 | -3.54 | -13.8 | -4.3 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -0.04 | -36.43 | -4.24 | -15.48 | 87.42 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 0.42 | -31.19 | -4.17 | -14.16 | 70.24 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.64 | 5.75 | 3.38 | 2.39 | 1.69 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.97 | 3.54 | 3.83 | 2.68 | 1.11 | |||||
Gross Profit, 5 Yr. CAGR % | 4.25 | -0.96 | 1.66 | 2.36 | 0.93 | |||||
EBITDA, 5 Yr. CAGR % | 3.47 | -5.61 | -4.1 | -2.13 | -0.41 | |||||
EBITA, 5 Yr. CAGR % | 3.37 | -7.52 | -5.8 | -3.22 | -0.95 | |||||
EBIT, 5 Yr. CAGR % | 2.99 | -8.12 | -6.31 | -3.56 | -1.08 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 2.1 | -7.7 | -27.84 | -18.66 | -2.58 | |||||
Net Income, 5 Yr. CAGR % | 1.84 | -8 | -28.95 | -19.34 | -2.91 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.38 | -10.1 | -7.62 | -4.36 | -1.44 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 2.55 | -6.96 | -28.13 | -18.66 | -2.39 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.77 | 3.24 | 2.7 | 1.33 | 5.09 | |||||
Inventory, 5 Yr. CAGR % | 11.16 | 10.47 | 6.58 | 4.47 | 2.87 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 12.78 | 12.72 | 11.55 | 10.56 | 3.03 | |||||
Total Assets, 5 Yr. CAGR % | 7.03 | 6.13 | 3.28 | 2.37 | -2.19 | |||||
Tangible Book Value, 5 Yr. CAGR % | 4.95 | 6.51 | -0.69 | -4.05 | -1.17 | |||||
Common Equity, 5 Yr. CAGR % | 6.71 | 0.51 | -21.24 | -10.11 | -18.78 | |||||
Cash From Operations, 5 Yr. CAGR % | 10.4 | -1.9 | 3.48 | -6.87 | -8.7 | |||||
Capital Expenditures, 5 Yr. CAGR % | 13.99 | 1.67 | 3.28 | 0.58 | -2.83 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -1.36 | -21.42 | 9.43 | -11.85 | 0.67 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -1.04 | -17.68 | 8.84 | -10.8 | 0.51 | |||||
Dividend Per Share, 5 Yr. CAGR % | 7.62 | 7.54 | 5.66 | 4.11 | 2.69 |
- Stock Market
- Equities
- CLX Stock
- Financials The Clorox Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















